Private Label Iomed Patch For Drug Delivery

B2B private label iontophoresis patches. Engineered with rotary-printed Ag/AgCl traces and synchronized impedance to match legacy dose controllers without triggering high-resistance faults.

These iontophoresis patches are configurable transdermal interfaces designed as drop-in equivalents for legacy Iomed hardware systems. Operating via galvanic electromigration, the substrate delivers localized ionic medication directly into subcutaneous tissue. Rather than standard wholesale, this product line is explicitly engineered for B2B clinical brands and pharmaceutical startups seeking a fully compliant, private-label delivery mechanism. We provide complete structural customization-from reservoir absorption capacities to specific Ag/AgCl ink ratios-ensuring the consumable syncs flawlessly with third-party constant-current generators.

The lamination stack is built upon a vapor-impermeable medical foam backing. To achieve predictable pharmacokinetics, a Silver/Silver-Chloride (Ag/AgCl) conductive track is applied using precision roll-to-roll screen printing. The critical manufacturing variable is the registration tolerance between this printed silver trace and the placement of the non-woven drug reservoir. Misalignment forces the DC current to arc across unbuffered zones. Our automated converting lines maintain a structural alignment tolerance strictly below 0.5mm. The chemical ratios of the Ag/AgCl ink are titrated to suppress the half-cell potential, stabilizing the interface voltage during continuous 4.0mA outputs. Standard OEM integration requires a minimum order quantity (MOQ) of 20,000 kits.

• Dose Controller Impedance Synchronization

  Legacy iontophoresis machines (like the Iomed Phoresor) possess aggressive safety circuits. If a private-label pad uses inferior carbon or an unbalanced Ag/AgCl mix, the electrical resistance spikes as the chemical buffer is consumed. The host controller interprets this as a "dry pad" or "high resistance" fault and immediately aborts the treatment. We calibrate the sheet resistance of our conductive ink specifically to mirror the impedance curve of legacy OEM pads. The resistance remains flat and predictable, allowing the hardware to deliver the full 80 mA-min dose without triggering false safety lock-outs.

   

• Roll-to-Roll Print Registration

  For brands scaling up their private label output, batch consistency is critical. Inconsistent manual printing causes microscopic variations in the Ag/AgCl thickness, leading to localized current crowding (thermal hotspots) where the silver layer is too thin. Our substrate is fabricated via high-speed, closed-loop optical alignment printing. This guarantees that the silver/chloride mass is distributed identically across every square millimeter of the active footprint, ensuring the 0.5 mA/cm² current density limit is mathematically maintained across thousands of production lots. 

   

• Turnkey UDI & Serialization Packaging 

  Launching a medical brand requires strict post-market traceability. Generic blank pouches fail FDA and MDR compliance audits. During the final packaging phase, we utilize inline thermal transfer units to print customized Unique Device Identification (UDI) barcodes, expiration chronologies, and batch-specific alphanumeric strings directly onto the high-barrier AL/PE foil pouches. This integration eliminates the need for secondary adhesive labels, providing the OEM client with immediate, audit-ready inventory control.

• Custom Reservoir Porosity: Depending on the viscosity of the target medication, the non-woven absorption layer can be modified. We adjust the fiber denier to prevent highly viscous solutions from pooling on the surface, ensuring rapid saturation into the active Ag/AgCl zone.

• Logistics Routing: The electro-chemical printing and lamination are executed in our China facility. Final custom die-cutting, UDI pouch serialization, and retail carton kitting route through our Vietnam hub, managing long-term supply chain resilience while optimizing North American B2B trade structures.

   

• Systems: Component fabrication, chemical handling, and final packaging execute entirely within audited ISO 13485:2016 and MDSAP regulatory frameworks. 

• Documentation Transfer: We provide sanitized formulation matrices and impedance verification reports to streamline the OEM client's domestic Class II regulatory submissions.

B2B clinical brands and pharmaceutical developers can request unbranded Ag/AgCl prototypes and impedance synchronization reports. / B2B 临床品牌和制药开发商可索取无品牌 Ag/AgCl 样机和阻抗同步报告.

👉 [Request Private Label Pad Samples]

Hot Tags: private label iomed patch for drug delivery, China private label iomed patch for drug delivery manufacturers, suppliers, factory, iontophoresis cortisone patch, Iontophoresis Pad, dexamethasone for iontophoresis patch, ionto pads, Iontophoresis Patches, iomed patch